Апо-Го Писалка

Апо-Го Писалка is a prescription injectable containing apomorphine hydrochloride hemihydrate for subcutaneous use. It is used to manage motor symptoms in Parkinson’s disease when oral medications are less effective. This product is manufactured by Stada Arzneimittel AG and sourced from the EU.

Apomorphine hydrochloride hemihydrate is primarily used to treat motor fluctuations in Parkinson’s disease, including ‘off’ episodes when symptoms return between doses of standard medication. It acts as a dopamine agonist and is administered via subcutaneous injection to provide rapid relief of rigidity, tremors, and bradykinesia. This option is often considered when oral therapies no longer provide consistent symptom control.

Users may experience a reduction in Parkinson’s motor symptoms shortly after injection, improving mobility and reducing periods of immobility. Some individuals report a temporary increase in energy or alertness following administration. Effects typically begin within 5 to 15 minutes and can last up to 90 minutes, depending on individual response.

This medication should only be used as directed by a healthcare professional. It may cause drowsiness or sudden sleep onset; avoid driving or operating machinery until you know how it affects you. Keep the injection pen and cartridges in a cool, dry place away from direct light. Do not use if the solution appears discolored or contains particles.

Apomorphine may interact with other central nervous system depressants, including alcohol and sedatives, potentially increasing drowsiness. Certain medications, such as those affecting blood pressure or heart rhythm, may require monitoring when used together. Always inform your healthcare provider about all medications and supplements you are taking.